AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2005

Aug 16, 2005

30339_dirs_2005-08-16_e06f33df-ee40-4c94-9778-a6b2037bf8ab.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-08-12

Reporting Person: HUGILL HERBERT L (Pres.of the Americas, Pharma.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-08-12	Common stocks	A	10.71	$26.6200	Acquired	6471.7603	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stocks	22242.9860	Direct

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement and tax withholding for vested shares.